The Genome Project versus private genetic research
The piece argues private firms offer faster genome mapping and related drug development, while federal efforts like the Human Genome Project face funding and timeline challenges. It notes private firms such as Incyte Pharmaceuticals push rapid progress and databases of genetic variations, suggesting tax dollars may be better used elsewhere.
MENTIONED IN THIS ARTICLE
Feds
U.S. Department of Energy
National Institutes of Health
Incyte Pharmaceuticals Inc
Parenting magic and the 1 2 3 discipline system
Monacharen reviews Thomas W. Phelan's 1 2 3 Magic advocating simple counting to curb misbehavior. The method denies children the power to provoke tantrums, using a 20 minute window and timeouts to restore parental authority. Charen notes the author’s practical humor and cautions balanced talk when calm.
MENTIONED IN THIS ARTICLE
Thomas W. Phelan
Phelan
Charen
Reagan White House
Picky FTC targets beer ads and low alcohol labels
Jacob Sullum critiques two FTC actions against Beck's beer and Allied Domecq, arguing the agency mocks consumer judgment. He notes the consent orders demand ad changes while questioning First Amendment implications and the agency’s overreach in defining unfair or deceptive practices.
MENTIONED IN THIS ARTICLE
Federal Trade Commission
Washington
FTC
Commission
Beck
Beer Institute
Davy Jones
North America
Allied Comecq Spirits & Wine
Domecaq
Comecq
Allied Domecq
Sullum
Reason Zine
Also Mentioned on This Page
OUR
Acdessamerican
Gary Newsom
Bill Salter
Ken Brodnax
Dunigan’s People
Monacharen
Possie
Iwiag Tabanemacnelly.com
Jacob Sullum
Picky Federal Agency
Illmore
Bruce Tinsley
Matar